by rss feed | Feb 1, 2024 | Lineage Cell Therapeutics, News Feeds, stem cell clinical trials, stem cells for deafness
A reader of The Niche recently asked me, “What about stem cells for deafness?” It’s a great question and, as they pointed out, stem cells for vision loss gets much more attention. I’ve covered the translational progress of stem cells to treat...
by rss feed | Oct 9, 2022 | Aijun Wang, Diana Farmer, News Feeds, stem cell clinical trials, weekly reads
It’s always great to read about stem cell clinical trials that are looking encouraging. Stem cell clinical trials Proving a new therapy is safe and effective is so challenging. Remarkably, there are more than 9,300 stem cell clinical trials listed for a...
by rss feed | May 10, 2022 | Google, News Feeds, stem cell clinical trials, stem cell clinics
A planned change to the Google ads policy will allow some ads for unproven cell and gene therapies. This shift, allowing educational ads, was just announced. I have a few concerns about this change that will start in July. Google ads policy and stem cells This move...
by rss feed | Jul 20, 2021 | Bioinformant, BioLife, Boston BioLife, News Feeds, stem cell clinical trials, stem cell clinics, stem cell muddy waters, stem cell therapy
How can you tell who to trust in the world of stem cell therapy? What information can a patient trust? Once upon a time about a dozen years ago it seemed a much simpler question. There were universities and biotech companies doing legit research as well as clinical...
by rss feed | Dec 22, 2020 | COVID-19, Mesoblast, News Feeds, Remestemcel-l, stem cell clinical trials, Stem cells for COVID-19
I’ve been closely following the arena of stem cells for COVID-19 since the pandemic broke including the efforts of Mesoblast. Mesoblast unlikely to meet primary endpoints in Phase III COVID trial Now, the firm got bad news as its DSMB reported that they are...
by rss feed | Oct 27, 2020 | IPS cells, IPS cells disease modeling, IPSC, IPSCs, Jun Takahashi, News Feeds, Shinya Yamanaka, stem cell clinical trials, stem cells for Parkinsons, Takanori Takebe, Takayuki Kikuchi
IPS cell research is a growing area of promise for regenerative medicine. These stem cells, also known as iPSCs or more formally as Induced Pluripotent Stem Cells, are engineered cells that are programmed to function the same way as embryonic stem cells. They can be...
